Concepedia

Natalie Mesens

NM

Statistics

Publications

8

Citations

298

H-Index

8

Active since

2008

Affiliations

Janssen (Belgium)(Current)

Johnson & Johnson (United States)

Natalie Mesens is an author at Janssen (Belgium) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

2008–2023

8

Publications

8

Zebrafish developmental toxicity assay: A fishy solution to reproductive toxicity screening, or just a red herring?

Kathleen Van den Bulck, Adrian Hill, Natalie Mesens et al. · Reproductive Toxicology · 2011 · 75 citations

, , +14

Evaluation of the Embryotoxic Potency of Compounds in a Newly Revised High Throughput Embryonic Stem Cell Test

Annelieke K. Peters, Margino Steemans, Erik Hansen et al. · Toxicological Sciences · 2008 · 46 citations

, , +16

Phospholipidosis in Rats Treated with Amiodarone: Serum Biochemistry and Whole Genome Micro-Array Analysis Supporting the Lipid Traffic Jam Hypothesis and the Subsequent Rise of the Biomarker BMP

Natalie Mesens, Miek Desmidt, Geert R. Verheyen et al. · Toxicologic Pathology · 2012 · 45 citations · Full text

, , +17

A 96-well flow cytometric screening assay for detecting in vitro phospholipidosis-induction in the drug discovery phase

Natalie Mesens, Steemans Margino, Poul Erik Hansen et al. · Toxicology in Vitro · 2008 · 34 citations

, , +12

Are zebrafish larvae suitable for assessing the hepatotoxicity potential of drug candidates?

Natalie Mesens, Alexander D. Crawford, Aswin Menke et al. · Journal of Applied Toxicology · 2015 · 33 citations

1–5 of 8